83520:EPSTEIN-BARR VIRUS VIRAL CAPSID ANTIGEN (VCA), IgA ANTIBODIES

Print View Attached Docs:
83520:EPSTEIN-BARR VIRUS VIRAL CAPSID ANTIGEN (VCA), IgA ANTIBODIES
Alias Names: EBV / VCA
Methodology: Indirect Fluorescent Antibody (IFA)
Edit Date: 11/1/2010
Performed: Tuesday-Saturday
Released: 1-3 days after setup at PeaceHealth Laboratories’ reference lab.
CPT Code: 86665-90
Specimen Collection Details
Collection: One 7.5 mL serum separator tube (SST).
Handling: Centrifuge and separate serum into a plastic tube.
Stability: 48 hours ambient, 7 days refrigerated, or 2 months frozen.
Standard Volume: 1 mL serum.
Minimum Volume: 0.4 mL serum.
Transport: Refrigerated.
Comments: VCA-IgA antibodies are useful for screening high risk populations for nasopharyngeal carcinoma. VCA-IgA antibody screening combined with detection of high titer EA IgA antibodies is useful in identifying early stage nasopharyngeal carcinoma.

Reference Range:
<1_10 titer

Family Medicine for America's Health